InvestorsHub Logo
Followers 3158
Posts 963891
Boards Moderated 194
Alias Born 09/04/2000

Re: mick post# 213

Wednesday, 04/08/2020 1:31:17 PM

Wednesday, April 08, 2020 1:31:17 PM

Post# of 258
GenMark Diagnostics, Inc (NASDAQ: GNMK) announced preliminary first-quarter results, expecting revenues of about $38.7 million, a 80% year-over-year increase.

The company noted that about 80% gross placements included interest in COVID-19 testing SARS-CoV-2 consumable revenues. Analysts, on average, estimate revenues of $24.8 million.

The company also raised its full-year revenue guidance from $100-$110 million to $112-$122 million, while the consensus calls for revenues of $108.58 million.

The stock climbed 29.56% to $5.83 in after-hours trading.

Zomedica Prices Offering of Common Stock, Warrants